MPCSH(SZ:000637)2018-10-30 16:00Financial Performance - Net profit attributable to shareholders decreased by 92.75% to CNY 1,689,610.92 for the reporting period[9] - Operating revenue for the period was CNY 1,139,535,426.65, reflecting a 2.98% increase year-on-year[9] - Basic earnings per share dropped by 93.33% to CNY 0.003[9] - Total profit decreased by 63.53% to ¥40,889,932.45, mainly due to a sluggish chemical market and rising raw material costs[18] - Net profit attributable to shareholders decreased by 67.07% to ¥24,938,251.75[18] - The company's net profit margin decreased due to rising costs, with operating costs constituting approximately 99.4% of total revenue[65] - The total profit for the current period is a loss of CNY 2,595,939.56, down from a profit of CNY 16,133,706.61 in the previous period[79] - The net profit for the third quarter was CNY 2,689.79 million, down 90.3% from CNY 27,626.09 million year-on-year[68] - The company's total profit for the quarter was CNY 3,980.21 million, a decline of 88.5% compared to CNY 34,618.46 million in the previous year[68] Assets and Liabilities - Total assets increased by 8.96% to CNY 1,317,421,868.99 compared to the end of the previous year[9] - Total liabilities increased to CNY 371,588,819.82 from CNY 219,178,159.56, showing a significant rise of about 69.5%[60] - The company reported a total current asset of ¥813,041,870.64 as of September 30, 2018, an increase from ¥693,360,271.56 at the beginning of the period, reflecting a growth of approximately 17.3%[57] - Cash and cash equivalents increased to ¥251,042,262.02 from ¥193,585,357.42, representing a growth of about 29.6%[57] - The company held financial assets measured at fair value totaling ¥34,448,463.73, down from ¥40,988,950.03, a decrease of approximately 15.9%[57] Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 72,087,953.73, down 10.76% compared to the previous year[9] - Cash flow from investing activities decreased by 175.58% to -¥49,107,178.76, driven by increased capital expenditures on technology upgrades and equity investments[18] - Cash flow from financing activities increased by 122.96% to ¥37,668,484.85, mainly due to new loans[18] - The investment activities generated a net cash outflow of CNY -49,107,178.76, compared to CNY -17,819,642.09 in the previous period[84] - The financing activities resulted in a net cash inflow of CNY 37,668,484.85, compared to a net outflow of CNY -164,039,452.77 in the previous period[84] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 38,247[13] - The largest shareholder, Beijing Taiyue Real Estate Development Co., Ltd., holds 29.50% of the shares[13] Research and Development - The company reported a research and development expense of CNY 2,672,260.50 for the quarter, reflecting ongoing investment in innovation[65] - The company incurred research and development expenses of CNY 8,085.62 million during the quarter[75] Market and Product Development - There were no significant new product developments or market expansions mentioned in the report[17] - The company plans to focus on market expansion and new product development in the upcoming quarters[70] - The company plans to sell its subsidiary Dongcheng Chemical Co., which accounts for over 50% of its main business revenue, pending regulatory approval[19] Impairment and Legal Matters - The company has recognized a 50% impairment provision for receivables from Runji Company, amounting to 2,415 million yuan, due to indications of impairment[37] - The ongoing lawsuit involving Maoming Wailian Petrochemical Co., Ltd. against Dongcheng regarding a sales contract dispute is still pending judgment as of the latest announcement[39] Audit and Compliance - The company has decided to change its auditing firm from Guangdong Zhengzhong Zhujiang CPA to RSM China CPA for the 2018 annual audit, pending shareholder approval[29] - The company did not conduct an audit for the Q3 report[89]